Clinical impacts of azithromycin on lung function and cytokines for athmatic patients

Fudan University Journal of Medical Sciences

Volumn 36, Issue 6, 2009, Pages 719-722

  He, Jian ^a   Zhu, Ning ^a   Chen, Xiao Dong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Asthma; Azithromycin; Cytokines; Induced sputum

Indexed keywords

EID: 72849134094     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Takizawa H, Desaki M, Ohtoshi T, et ai. Erythromycin supperlesses interleukin-6 expression by human bronchial epithelial cells:a potential mechanism of its anti-inflammatory action[J]. Biochem Biophys Res Commun, 1995, 210(3): 781-786.
2. Amsden GW. Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community- acquired respiratory tract infections and chronic inflammatorypulmonary conditions? [J]. J Antimicrob Chemother, 2005, 55(1):10-21.
3. [4] Hatipoglu U, Rubinstein I. Low-dose, long-term macrolide therapy in asthma: an overview[J]. Clin MoI Allergy, 2004, 2(1):4. (Pubitemid 39111884)
4. Wales D, Woodhead M. The anti-inflammatory effects of macrolides[J]. Thorax, 1999, 54(2):S58-S62.
5. [6] Sharma S, Jaffe A, Dixon G. Immunomodulatory Effects of MacrolideAntibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis [J]. Paediatr Drugs, 2007 9(2):107-118. (Pubitemid 46624563)
6. Rubin BK, Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease [J]. Chest, 2004, 125(2):70S-78S.
7. [8] Kostadima E, Tsiodras S, Alexopoulos EI, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma[J]. Eur Respir J, 2004, 23(5):714-717. (Pubitemid 38618141)
8. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma[J]. N Engl J Med, 2006, 354(15):1 589-1 600.
9. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma[J]. Am J Respir Crit Care Med, 2008, 177(2):148-155.
10. Ekici A.Ekici M, Erdemoglu AK. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma[J]. J Asthma, 2002, 39(2):181-185.
11. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary[J]. Eur Respir J, 2008, 31(1):143-178.
12. Kozyskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life[J]. Chest, 2007, 131 (6):1 753-1 759.
13. Kiss A, Montes M, Susarla S, et al. A new mechanism regulating the initiation of allergic airway inflammation[J]. J Allergy Clin Immunol, 2007, 120(2):334-342.
14. [16] Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma [J]. Mediators In flamm, 2001, 10(2):51-59. (Pubitemid 32522160)
15. [17] Brown V, Warke TJ, Shields MD, et al. T cell cytokine profiles in childhood asthma [J]. Throax, 2003, 58 (4): 311-316. (Pubitemid 36411416)
16. [18] Shimizu T, Kato M, Mochizuki H, et al. Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma[J]. Chest, 1994, 106(2):458-461. (Pubitemid 24252043)